Literature DB >> 20543270

Using virtual humans to alleviate social anxiety: preliminary report from a comparative outcome study.

Genevève Robillard1, Stéphane Bouchard, Stéphane Dumoulin, Tanya Guitard, Evelyne Klinger.   

Abstract

Empirical studies have consistently shown the effectiveness of a multicomponent CBT treatment of social anxiety disorder (SAD). Previous outcome studies on virtual reality and SAD have focused on people suffering from fear of public speaking and not full blown SAD. In this study, 45 adults receiving a DSM-IV-TR diagnostic of social anxiety were randomly assigned to traditional CBT treatment (with in vivo exposure), CBT-VR combined treatment, or a waiting list. Results show significant reduction of anxiety on all questionnaires as well as statistically significant interactions between both treatment groups and the waiting list.

Entities:  

Mesh:

Year:  2010        PMID: 20543270

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  9 in total

Review 1.  The Use of Virtual Reality Technology in the Treatment of Anxiety and Other Psychiatric Disorders.

Authors:  Jessica L Maples-Keller; Brian E Bunnell; Sae-Jin Kim; Barbara O Rothbaum
Journal:  Harv Rev Psychiatry       Date:  2017 May/Jun       Impact factor: 3.732

2.  How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence.

Authors:  Pim Cuijpers; Ioana A Cristea; Eirini Karyotaki; Mirjam Reijnders; Marcus J H Huibers
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

3.  STUDY PROTOCOL: EXPOSURE IN VIRTUAL REALITY FOR SOCIAL ANXIETY DISORDER - a randomized controlled superiority trial comparing cognitive behavioral therapy with virtual reality based exposure to cognitive behavioral therapy with in vivo exposure.

Authors:  Lars Clemmensen; Stéphane Bouchard; Johan Rasmussen; Trine Theresa Holmberg; Jakob Hyldig Nielsen; Jens Richardt Møllegaard Jepsen; Mia Beck Lichtenstein
Journal:  BMC Psychiatry       Date:  2020-01-30       Impact factor: 3.630

4.  The Effects of Virtual Reality Treatment on Prefrontal Cortex Activity in Patients With Social Anxiety Disorder: Participatory and Interactive Virtual Reality Treatment Study.

Authors:  Hojun Lee; JongKwan Choi; Dooyoung Jung; Ji-Won Hur; Chul-Hyun Cho
Journal:  J Med Internet Res       Date:  2021-12-17       Impact factor: 5.428

Review 5.  Virtual Reality Exposure Therapy for Treating Social Anxiety: A Scoping Review of Treatment Designs and Adaptation to Stuttering.

Authors:  Ian Chard; Nejra van Zalk
Journal:  Front Digit Health       Date:  2022-02-25

6.  Standard CBT versus integrative and multimodal CBT assisted by virtual-reality for generalized anxiety disorder.

Authors:  Cosmin Octavian Popa; Florin Alin Sava; Simona Muresan; Alina Schenk; Cristiana Manuela Cojocaru; Lorena Mihaela Muntean; Peter Olah
Journal:  Front Psychol       Date:  2022-09-28

7.  Assessing public speaking fear with the short form of the Personal Report of Confidence as a Speaker scale: confirmatory factor analyses among a French-speaking community sample.

Authors:  Alexandre Heeren; Grazia Ceschi; David P Valentiner; Vincent Dethier; Pierre Philippot
Journal:  Neuropsychiatr Dis Treat       Date:  2013-05-03       Impact factor: 2.570

8.  Virtual reality exposure using three-dimensional images for the treatment of social phobia.

Authors:  Cristiane M Gebara; Tito P de Barros-Neto; Leticia Gertsenchtein; Francisco Lotufo-Neto
Journal:  Braz J Psychiatry       Date:  2015-11-13       Impact factor: 2.697

9.  Group cognitive behavioural therapy with virtual reality exposure versus group cognitive behavioural therapy with in vivo exposure for social anxiety disorder and agoraphobia: a protocol for a randomised clinical trial.

Authors:  Benjamin Arnfred; Peter Bang; Carsten Hjorthøj; Clas Winding Christensen; Kirsten Stengaard Moeller; Morten Hvenegaard; Lone Agerskov; Ulrik Krog Gausboel; Ditte Soe; Peter Wiborg; Christopher Ian Schøler Smith; Nicole Rosenberg; Merete Nordentoft
Journal:  BMJ Open       Date:  2022-02-02       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.